These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30560308)
1. A squamous cell carcinoma in a young woman with Lynch syndrome. Adan F; Crijns MB; Dekker E; Bastiaansen BAJ; Lapid O; Snaebjornsson P; Rosenberg EH; van Leerdam ME; Bekkenk MW Fam Cancer; 2019 Apr; 18(2):193-196. PubMed ID: 30560308 [TBL] [Abstract][Full Text] [Related]
2. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge. Ponti G; Manfredini M; Tomasi A; Pellacani G Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115 [TBL] [Abstract][Full Text] [Related]
3. The frequency of Muir-Torre syndrome among Lynch syndrome families. South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome. Simic D; Dummer R; Freiberger SN; Ramelyte E; Barysch MJ Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065301 [TBL] [Abstract][Full Text] [Related]
5. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164 [TBL] [Abstract][Full Text] [Related]
6. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
7. A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma. Kientz C; Joly MO; Faivre L; Clemenson A; Dalac S; Lepage C; Chapusot C; Jacquot C; Schiappa R; Lebrun M Hered Cancer Clin Pract; 2017; 15():6. PubMed ID: 28507641 [TBL] [Abstract][Full Text] [Related]
8. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205 [TBL] [Abstract][Full Text] [Related]
9. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714 [TBL] [Abstract][Full Text] [Related]
10. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
11. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome. Perera S; Ramyar L; Mitri A; Pollett A; Gallinger S; Speevak MD; Aronson M; Bapat B J Hum Genet; 2010 Jan; 55(1):37-41. PubMed ID: 19911012 [TBL] [Abstract][Full Text] [Related]
12. Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome. Lamba AR; Moore AY; Moore T; Rhees J; Arnold MA; Boland CR Fam Cancer; 2015 Jun; 14(2):259-64. PubMed ID: 25637498 [TBL] [Abstract][Full Text] [Related]
13. First reported case of a squamous cell carcinoma arising in the duodenum in a patient with Lynch syndrome. Amjad AI; Singhi AD; Balaban EP; Dudley B; Brand RE; Bahary N Int J Clin Exp Pathol; 2014; 7(12):8988-95. PubMed ID: 25674277 [TBL] [Abstract][Full Text] [Related]
14. [Muir-Torre syndrome and Turcot syndrome]. Velter C; Caussade P; Fricker JP; Cribier B Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262 [TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome with exclusive skin involvement: time to consider a molecular definition? Vaisfeld A; Calicchia M; Pomponi MG; Lucci-Cordisco E; Reggiani-Bonetti L; Genuardi M Fam Cancer; 2019 Oct; 18(4):421-427. PubMed ID: 31292797 [TBL] [Abstract][Full Text] [Related]
16. [Muir-Torre syndrome]. Jonas J; Kruse R; Bähr R Chirurg; 2002 Apr; 73(4):366-9. PubMed ID: 12063922 [TBL] [Abstract][Full Text] [Related]
17. Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort. Zhong CS; Horiguchi M; Uno H; Ukaegbu C; Chittenden A; LeBoeuf NR; Syngal S; Nambudiri VE; Yurgelun MB J Am Acad Dermatol; 2023 Jun; 88(6):1282-1290. PubMed ID: 36773823 [TBL] [Abstract][Full Text] [Related]
18. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature. Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327 [TBL] [Abstract][Full Text] [Related]
19. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Suspiro A; Fidalgo P; Cravo M; Albuquerque C; Ramalho E; Leitão CN; Costa Mira F Am J Gastroenterol; 1998 Sep; 93(9):1572-4. PubMed ID: 9732950 [TBL] [Abstract][Full Text] [Related]